Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.51 |
| ▸ | SQLE | Q14534 | 4/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23787675 | 0.90 | PTPN1 (0.49) | PTPN1SQLEALOX15ALDH1A1KDM1A | |
| SCHEMBL889883 | 0.88 | SQLE (0.55) | PTPN1SQLEALOX15ALDH1A1KDM1A | |
| SCHEMBL8978494 | 0.87 | PTPN1 (0.65) | PTPN1ALOX15ALDH1A1KDM1APTGS1 | |
| SCHEMBL8978492 | 0.87 | PTPN1 (0.65) | PTPN1ALOX15ALDH1A1KDM1APTGS1 | |
| SCHEMBL8978480 | 0.83 | KMT2A (0.52) | SQLEALOX15ALDH1A1KDM4EMAPT | |
| SCHEMBL8978478 | 0.83 | KMT2A (0.52) | SQLEALOX15ALDH1A1KDM4EMAPT | |
| SCHEMBL8978488 | 0.81 | PTPN1 (0.67) | PTPN1ALOX15KDM1APTGS1PDE4A | |
| SCHEMBL8978519 | 0.81 | ALOX15 (0.52) | PTPN1SQLEALOX15ALDH1A1KDM1A | |
| SCHEMBL8978516 | 0.81 | ALOX15 (0.52) | PTPN1SQLEALOX15ALDH1A1KDM1A | |
| SCHEMBL8978484 | 0.81 | PTPN1 (0.67) | PTPN1ALOX15KDM1APTGS1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9193872-B2 | Photo-crosslinkable antifouling compositions, films obtained from said compositions, and corresponding uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-11-24 | — | — | US | disclosed |
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | ALG1, ALG8, PHOSPHO1 | PTPN1 3168/4885SQLE 94/4885ALOX15 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.